Related references
Note: Only part of the references are listed.Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs
Kati Erdmann et al.
BMC CANCER (2014)
Molecular Biomarkers in Advanced Renal Cell Carcinoma
Pablo Maroto et al.
CLINICAL CANCER RESEARCH (2014)
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
Jessica Okosun et al.
NATURE GENETICS (2014)
Significance of Cyclooxygenase 2, EZH-2 Polycomb Group and p53 Expression in Actinic Keratosis and Squamous Cell Carcinomas of the Skin
Anna-Maria Athanassiadou et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2013)
Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis
Shigeki Nakagawa et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
EZH2 Promotes E2F-Driven SCLC Tumorigenesis through Modulation of Apoptosis and Cell-Cycle Regulation
Roland Hubaux et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Re: Long Non-Coding RNA H19 Increases Bladder Cancer Metastasis by Associating with EZH2 and Inhibiting E-Cadherin Expression Editorial Comment
Anthony Atala
JOURNAL OF UROLOGY (2013)
Expression of Polycomb Targets Predicts Breast Cancer Prognosis
Alba Jene-Sanz et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome
Xiao Li et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis
Xiao Li et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
New mutations and pathogenesis of myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2011)
Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
Michiel Smits et al.
PLOS ONE (2011)
EZH2 Depletion Blocks the Proliferation of Colon Cancer Cells
Bettina Fussbroich et al.
PLOS ONE (2011)
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
O. Fluge et al.
BRITISH JOURNAL OF CANCER (2009)
Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2
Andrei V. Ougolkov et al.
CLINICAL CANCER RESEARCH (2008)
Renal-cell carcinoma
HT Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
